Although the studies of the last decade have shown a decreased mortality rate in acromegaly, we believe is important to review this topic, because cardiovascular complications remain among the main cause of death in acromegaly, especially after long-term exposition to high levels of GH and IGF-1 (2–4). The gene discussed is GH1; the disease is acromegaly.